Cigna CEO promises Express Scripts merger will curb rising drug costs

By Joe Williams

Published May 3, 2018 9:42am ET

Add Washington Examiner on Google

Cigna CEO promises Express Scripts merger will curb rising drug costs — Total revenues for Cigna in 2017 were $41.6 billion, an increase of 5 percent over 2016, driven by continued growth in Cigna's targeted customer segments. | (Michael Nagle/Bloomberg)

Cigna’s chief executive officer defended the company’s merger with the top U.S. pharmacy benefit manager on Thursday, arguing that the transaction will help the insurer curb growing healthcare costs for corporate clients.

The Bloomfield, Conn.-based company expects the $52 billion merger with Express Scripts to close by the end of 2018, but an ongoing review by the Department of Justice may affect that timeline.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Business Health Healthcare Mergers and Acquisitions News Regulations